Renal amyloidosis surgery: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Indications== | ==Indications== | ||
* | *In renal amyloidosis, surgery is usually reserved for patients developed with end stage renal disease.<ref name="pmid225623702">{{cite journal |vauthors=Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS |title=Outcome of patients with amyloidosis after renal transplantation: a single-center experience |journal=Int J Artif Organs |volume=35 |issue=6 |pages=444–9 |date=June 2012 |pmid=22562370 |doi=10.5301/ijao.5000091 |url=}}</ref> | ||
==Surgery== | ==Surgery== | ||
=== Renal transplantation === | |||
*The patients with renal amyloidosis are good candidates for transplantation.<ref name="pmid22562370">{{cite journal |vauthors=Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS |title=Outcome of patients with amyloidosis after renal transplantation: a single-center experience |journal=Int J Artif Organs |volume=35 |issue=6 |pages=444–9 |date=June 2012 |pmid=22562370 |doi=10.5301/ijao.5000091 |url=}}</ref> | *The patients with renal amyloidosis are good candidates for transplantation.<ref name="pmid22562370">{{cite journal |vauthors=Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS |title=Outcome of patients with amyloidosis after renal transplantation: a single-center experience |journal=Int J Artif Organs |volume=35 |issue=6 |pages=444–9 |date=June 2012 |pmid=22562370 |doi=10.5301/ijao.5000091 |url=}}</ref> | ||
*In primary amyloidosis, renal transplantation is considered and it will improve long-term survival and quality of life.<ref name="pmid24497558">{{cite journal |vauthors=Mahmood S, Palladini G, Sanchorawala V, Wechalekar A |title=Update on treatment of light chain amyloidosis |journal=Haematologica |volume=99 |issue=2 |pages=209–21 |date=February 2014 |pmid=24497558 |pmc=3912950 |doi=10.3324/haematol.2013.087619 |url=}}</ref> | *In primary amyloidosis, renal transplantation is considered and it will improve long-term survival and quality of life.<ref name="pmid24497558">{{cite journal |vauthors=Mahmood S, Palladini G, Sanchorawala V, Wechalekar A |title=Update on treatment of light chain amyloidosis |journal=Haematologica |volume=99 |issue=2 |pages=209–21 |date=February 2014 |pmid=24497558 |pmc=3912950 |doi=10.3324/haematol.2013.087619 |url=}}</ref> | ||
Revision as of 00:18, 28 June 2018
|
Renal amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Template:Renal amyloidosis On the Web |
|
American Roentgen Ray Society Images of Renal amyloidosis surgery |
|
Risk calculators and risk factors for Renal amyloidosis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Indications
- In renal amyloidosis, surgery is usually reserved for patients developed with end stage renal disease.[1]
Surgery
Renal transplantation
- The patients with renal amyloidosis are good candidates for transplantation.[2]
- In primary amyloidosis, renal transplantation is considered and it will improve long-term survival and quality of life.[3]
References
- ↑ Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS (June 2012). "Outcome of patients with amyloidosis after renal transplantation: a single-center experience". Int J Artif Organs. 35 (6): 444–9. doi:10.5301/ijao.5000091. PMID 22562370.
- ↑ Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS (June 2012). "Outcome of patients with amyloidosis after renal transplantation: a single-center experience". Int J Artif Organs. 35 (6): 444–9. doi:10.5301/ijao.5000091. PMID 22562370.
- ↑ Mahmood S, Palladini G, Sanchorawala V, Wechalekar A (February 2014). "Update on treatment of light chain amyloidosis". Haematologica. 99 (2): 209–21. doi:10.3324/haematol.2013.087619. PMC 3912950. PMID 24497558.